GRFS

Grifols, S.A.

Healthcare›Drug Manufacturers - General|NASDAQ Global Select|ES

Price

$8.24

Market Cap

$6.97B

Beta

1.21

P/E

14.3

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+4.06%

EPS Growth (YoY)+159.86%

Revenue CAGR 3Y+6.87%

P/E Ratio14.3

PEG Ratio0.09

FCF Yield+11.07%

Debt / Equity1.66

Interest Coverage2.1x

No credit card required

Already have an account? Sign in to view the full analysis for GRFS.